NCT05651334

Brief Summary

The primary objective of this study is to examine the effects of repetitive transcranial magnetic stimulation (rTMS) on a regulation of craving task (ROC task) and evaluate the feasibility of targeting rTMS via fMRI based neuronavigation. Specifically, we will examine BOLD activation within the DLPFC when control over craving is exerted in order to identify if 1) the task produces reliable activations in an area capable of being targeted by a standard figure-8 coil and 2) examine if the coordinates of the area are distinct from the area targeted via anatomical neuronavigation alone. Last, we will examine if rTMS, compared to sham, is capable of improving cognitive control over craving measured at outcome. The current pilot study will examine these aims in a sample of tobacco dependent adults (N=16) (with final sample size dependent on availability of funds).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Nov 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2022

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

November 28, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2023

Completed
Last Updated

March 8, 2024

Status Verified

March 1, 2024

Enrollment Period

8 months

First QC Date

November 28, 2022

Last Update Submit

March 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Regulation of Craving Task

    Self report ratings of cue induced craving for smoking after instruction. Specifically, differences in craving following positive vs. negative instructions will be compared between active stimulation and sham stimulation groups at the final outcome session, accounting for baseline values (similar to methods detailed in (Kober, Kross, Mischel, Hart, \& Ochsner, 2010). Kober, H., Kross, E. F., Mischel, W., Hart, C. L., \& Ochsner, K. N. (2010). Regulation of craving by cognitive strategies in cigarette smokers. Drug and Alcohol Dependence, 106(1), 52-55. doi:10.1016/j.drugalcdep.2009.07.017

    Assessed during the baseline session and repeated at the outcome session (following stimulation), occurring on average less than one month apart. Primary outcome measure are the ratings collected at the final outcome session.

  • Brief Questionnaire of Smoking Urges (QSU - Brief)

    Self report assessment smoking urges will be compared between active stimulation and sham stimulation groups at the final outcome session, accounting for baseline values.

    Assessed during the baseline session and repeated at the outcome session (following stimulation), occurring on average less than one month apart. Primary outcome measure are the ratings collected at the final outcome session.

Study Arms (2)

Active repetitive Transcranial Magnetic Stimulation (rTMS)

EXPERIMENTAL

rTMS will be delivered with a MagPro R-30 magnetic stimulator (MagVenture, Farum, Denmark) Cool-B65 A/P (Active/Placebo). Participants will receive 900 pulses of 20 Hz rTMS per session at 110% of the Motor threshold (MT) (45 20-pulse trains of 1 second duration with an inter-train interval of 20 seconds). MT will be established to determine the intensity of stimulation for each participant, as recommended by safety guidelines. MT will be defined as the amount of energy required to induce a visible twitch in contralateral hand in at least 50% of stimulations. The target stimulation site will be the left DLPFC, specifically: located 6 cm anterior of the MT site identified with assistance from the neuro-navigation system to ensure that the target is located in the middle of the frontal gyrus, in the lateral part of Brodmann Area (BA) 9, near the border of BA 46.

Device: Active repetitive Transcranial Magnetic Stimulation

Sham repetitive Transcranial Magnetic Stimulation (rTMS)

SHAM COMPARATOR

Sham rTMS will appear identical to active treatment, with the exception that the sham side of the coil will be used resulting in no stimulation being applied to the participant, while providing a sensation of stimulation.

Device: Sham repetitive Transcranial Magnetic Stimulation

Interventions

Active stimulation

Active repetitive Transcranial Magnetic Stimulation (rTMS)

Sham stimulation

Sham repetitive Transcranial Magnetic Stimulation (rTMS)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Smokers endorsing atleast moderate dependence (total Fagerstrom for Cigarette Dependence score \> 4)
  • Endorsing no specific plan to quit smoking in the next 3 months.
  • Must meet safety guidelines for application of rTMS
  • years of age
  • Smoked cigarettes regularly for at least one year
  • Currently smoke at least 10 cigarettes per day
  • Have a carbon monoxide (CO) level greater or equal to 10 ppm
  • Currently be using no other nicotine products.

You may not qualify if:

  • Subjects will be excluded if they meet criteria for current alcohol (moderate - severe), current substance dependence, current affective disorder (depression, dysthymia, or mania) or current psychotic symptoms as assessed by the (MINI) International Neuropsychiatric Exam
  • Are currently pregnant or lactating, or intend to become pregnant
  • Have a health condition for which rTMS is contraindicated
  • Submit a urine drug screen positive for illicit substances or substance misuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Smoking

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Condition assignment using the URN procedure will be conducted by the research coordinator who is not involved in treatment delivery or outcome assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to active or sham transcranial magnetic stimulation. Assignment to condition will be conducted using the Urn randomization procedure to ensure balancing on nicotine dependence, and age.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 15, 2022

Study Start

November 8, 2022

Primary Completion

July 13, 2023

Study Completion

July 13, 2023

Last Updated

March 8, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

NO IPD will be shared.

Locations